Introduction
Trypanosoma cruzi, a parasite that causes Chagas disease, is exclusively found in the Americas (mostly in rural, impoverished areas of Latin America) and is transferred by insects. It can infect both humans and animals. American trypanosomiasis is another name for Chagas disease, an infection caused by T. cruzi.
The effects of Chagas disease extend beyond particular rural communities where vector-borne transmission diseases spread by insects occur. The epidemiology and geographic distribution of Chagas disease have changed due to significant population shifts from rural to urban areas and other parts of the world. Control measures should concentrate on preventing transmission from organ transplants, blood transfusions, and mother-to-child (congenital) transmission in the United States and other areas where Chagas disease is currently present but is not endemic.
What Is the Pathophysiology of Chagas Disease?
-
Chagas disease typically spreads through the transmission of vectors. Triatomine insects, also known as Riduvid bugs, feed on the blood of an individual who is already afflicted, therefore becoming infected themselves.
-
The insects transmit the disease through their excrement and urine. Infection with T. cruzi in humans happens when they come into contact with the feces or urine of insects that are infected. The infection commonly infiltrates the host's body either through a wound caused by the host's scratching after being bitten by an insect or through the mucus membranes of the conjunctiva.
-
Additional transmission methods include organ transplants, blood transfusions, vertical transmission, breast milk, and oral transmission from consuming contaminated foods.
-
The interval between transmission and the onset of symptoms is usually one to two weeks.
How Do the Individuals Acquire Chagas Disease?
Individuals might contract infections through several means. Vector-borne transmission is the primary mode of Chagas disease transmission in regions where the disease is prevalent. The insects responsible for transmitting diseases are referred to as triatomine bugs.
Individuals may also get the infection by
-
The modes of transmission include congenital transmission (from a pregnant woman to infant), blood transfusions, organ donation, consumption of uncooked food contaminated with feces from infected triatomine bugs, and accidental laboratory exposure.
-
Breastfeeding is typically deemed safe, even in cases where the mother is afflicted with Chagas disease. Nevertheless, if the mother has fissured nipples or detects blood in the breast milk, should utilize a breast pump and dispose of the milk until the nipples have healed and the bleeding has ceased.
Chagas disease is not transferred through person-to-person transmission, such as through casual contact with infected individuals or animals, like how a cold or the flu is spread.
Should Family Members Get Tested for the Illness if Someone in the Family Has Chagas Disease?
Testing should be conducted if the following conditions are achieved:
-
They could have contracted Chaga’s disease through the same means, such as vector-borne transmission.
-
Children born after a person gets an infection or other factors may also indicate their likelihood of having Chagas disease.
What Are the Symptoms of the Disease?
Chagas disease can manifest as an acute, short-lived illness or a chronic, persistent ailment. The symptoms vary in intensity from mild to severe. However, a significant number of individuals remain asymptomatic until the chronic phase.
Initial Stage: The initial stage of Chagas disease, known as the acute phase, typically lasts for weeks or months and is frequently asymptomatic. Signs and symptoms, if present, are often modest and may encompass:
-
Inflammation at the site of infection.
-
Pyrexia (an elevated body temperature).
-
Exhaustion skin eruption.
-
Muscular discomfort.
-
Swelling of the eyelid.
-
Cephalalgia (headache that is localized).
-
Anorexia (anxiety-induced loss of appetite).
-
Symptoms such as nausea, diarrhea, or vomiting.
-
Enlarged lymph nodes.
-
Hepatosplenomegaly (enlarged liver).
Manifestations and indications that arise during the acute period generally resolve spontaneously. Untreated infections of Chagas disease may progress to the chronic phase in certain instances.
Chronic Phase: Chronic phase refers to a long-lasting stage or period of a particular condition or disease. The chronic phase of Chagas disease may manifest signs and symptoms either ten to 20 years after the original infection or not at all.
Severe Chagas disease may manifest with the following signs and symptoms:
-
Arrhythmia(irregular heart rhythm).
-
Cardiac insufficiency.
-
Dysphagia( difficulty or discomfort in swallowing) caused by esophageal enlargement.
-
Abdominal discomfort or difficulty passing stool caused by an enlarged colon.
What Is the Treatment for Chagas Disease?
Age, symptoms, and overall health will all influence the course of treatment. Moreover, the severity of the condition will also play a role. Chagas disease is most effectively treated at an early stage. Treatment for the parasite itself may become ineffective upon subsequent disease diagnosis. Complications may, however, be treated. The following may be suggested as a treatment:
-
Administration of antiparasitic medication to eradicate the parasite.
-
Providing symptomatic treatment to address the symptoms and indicators of infection.
The efficacy of antiparasitic treatment is most important when administered promptly after infection onset. However, it can also be useful in situations beyond the acute period. Benznidazole has received FDA approval for administration to children aged two to 12 and can be purchased commercially. The majority of individuals do not require hospitalization for their therapy.
Conclusion
Chagas disease, previously limited to impoverished rural regions, has become a global public health issue and is expected to continue being so in the foreseeable future. Nevertheless, with the continuous advancements in monitoring, treatment, and measures to eradicate disease-carrying vectors, the prospect of successfully eliminating the disease in the foreseeable future is becoming more and more achievable. The future success in combating Chagas disease relies on the efficient management of newly emerging infectious areas, the maintenance of elevated levels of public awareness and government commitment to disease control, and the ongoing enhancements in diagnostic, therapeutic, and surveillance technologies. To achieve ongoing progress and maybe eradicate Chagas disease in the next 100 years, it is crucial to consistently use and enhance the lessons acquired from combating T. cruzi infection from the past century.
